CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
HAIN
The Hain Celestial Group, Inc.
There isn't enough reported data to score HAIN yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
HAIN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Healthy | |
| Weak |
HAIN's cash flow is currently healthy, but its revenue, profitability and balance sheet are under pressure.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
HAIN PE Valuation
HAIN has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over HAIN on the outlook, with more favorable revenue expectations.
HAIN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect HAIN's losses to shrink, with revenue declining.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over HAIN on earnings quality, reporting a profit while its opponent remains loss making.
HAIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.25 | +$2.65 |
| Q2 2026 | -$3.36 | +$2.53 |
| Q1 2026 | -$5.71 | -$2.82 |
| Q4 2025 | -$6.03 | -$4.09 |
| Q3 2025 | -$5.90 | -$4.96 |
| Q2 2025 | -$5.89 | -$5.05 |
| Q1 2025 | -$2.89 | -$1.87 |
| Q4 2024 | -$1.94 | -$0.17 |
HAIN lost $3.25 per share over the past year, a smaller loss than the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over HAIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over HAIN on profitability, with a higher operating margin.
HAIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $260.3M | -29% |
| Q2 2026 | $263.1M | -28% |
| Q1 2026 | $338.4M | -13% |
| Q4 2025 | $384.1M | -6.7% |
| Q3 2025 | $367.9M | -6.8% |
| Q2 2025 | $363.3M | -13% |
| Q1 2025 | $390.4M | -11% |
| Q4 2024 | $411.5M | -9.4% |
HAIN's revenue has slid since its 2020 peak: $260M last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.8% | -3.9 points |
| Q2 2026 | -21% | +48 points |
| Q1 2026 | -12% | +19 points |
| Q4 2025 | -26% | -3.4 points |
| Q3 2025 | -1.9% | -2.6 points |
| Q2 2025 | -69% | -72 points |
| Q1 2025 | -31% | -25 points |
| Q4 2024 | -22% | -22 points |
HAIN's operating margin was −5.8% last quarter, down 3.9 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
HAIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.8M | -$9.1M |
| Q2 2026 | $6.8M | +$15.7M |
| Q1 2026 | $34.5M | +$36.8M |
| Q4 2025 | $30M | +22% |
| Q3 2025 | -$13.7M | +$2.8M |
| Q2 2025 | -$8.9M | -129% |
| Q1 2025 | -$2.3M | -108% |
| Q4 2024 | $24.5M | +65% |
HAIN has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over HAIN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
HAIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +266K shares |
| 1 year | +0.8% | +693K shares |
| 3 years | +1.7% | +1.5M shares |
| 5 years | -6.6% | -6.4M shares |
| Available history | -13% | -13.6M shares |
HAIN has 91M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $13.1M |
| Q1 2022 | $130.5M |
| Q4 2021 | $89.8M |
| Q3 2021 | $177.1M |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
HAIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 22.7x | High |
| Q2 2024 | 26.8x | High |
| Q1 2024 | 25.7x | High |
| Q4 2022 | 6.0x | High |
| Q3 2022 | 5.9x | High |
| Q2 2022 | 5.4x | High |
| Q1 2022 | 4.3x | High |
| Q4 2021 | 3.4x | Elevated |
HAIN's net debt is more than 20 years of its operating earnings (EBITDA), up from 5.9 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
HAIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 2.5 | Oversold |
HAIN's weekly RSI is 29 (oversold) and its Stochastic is 2 (oversold).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
HAIN PE vs Consumer Defensive Sector
| Metric | HAIN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
HAIN has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over HAIN on trend strength, trading above more of its moving averages.
HAIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.30 | 53% below |
| 20 week MA | $0.48 | 71% below |
| 50 week MA | $0.72 | 81% below |
| 100 week MA | $1.72 | 92% below |
| 200 week MA | $6.29 | 98% below |
HAIN is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over HAIN on returns for 2026, with the stronger performance.
HAIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.6 | $40.0 | +56% |
| 2021 | $40.0 | $41.6 | +4.1% |
| 2022 | $41.6 | $15.9 | -62% |
| 2023 | $15.9 | $11.0 | -31% |
| 2024 | $11.0 | $6.50 | -41% |
| 2025 | $6.50 | $1.16 | -82% |
| 2026 YTD | $1.16 | $0.14 | -88% |
HAIN has finished four years in a row lower, and it's down 88% so far in 2026.